Modivcare Stock Beta

MODV Stock

USD 4.18 0.43 9.33%

ModivCare fundamentals help investors to digest information that contributes to ModivCare's financial success or failures. It also enables traders to predict the movement of ModivCare Stock. The fundamental analysis module provides a way to measure ModivCare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ModivCare stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ModivCare Company Beta Analysis

ModivCare's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

Covariance

Variance

More About Beta | All Equity Analysis

Current ModivCare Beta

0.49

Most of ModivCare's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ModivCare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

ModivCare Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for ModivCare is extremely important. It helps to project a fair market value of ModivCare Stock properly, considering its historical fundamentals such as Beta. Since ModivCare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ModivCare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ModivCare's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Accounts Payable	Long Term Debt	Good Will	Total Liab	Treasury Stock	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Retained Earnings	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.25	0.77	0.96	0.95	0.98	-0.75	0.95	0.67	0.92	0.92	0.12	0.9	0.77	0.64	0.73	-0.02	0.01	0.65	0.94	0.84	0.24	0.84	-0.06	0.89	-0.84	-0.91
Total Stockholder Equity	0.25		-0.03	-0.04	0.18	0.06	-0.54	0.16	0.6	0.06	-0.11	0.9	0.15	0.5	-0.35	0.32	0.55	0.14	0.66	-0.07	0.48	-0.02	-0.2	0.77	0.06	0.07	-0.1
Accounts Payable	0.77	-0.03		0.79	0.69	0.8	-0.45	0.71	0.46	0.86	0.83	-0.25	0.86	0.53	0.83	0.45	-0.23	0.3	0.43	0.78	0.58	0.33	0.74	-0.25	0.6	-0.7	-0.59
Long Term Debt	0.96	-0.04	0.79		0.94	0.99	-0.64	0.93	0.5	0.93	0.99	-0.13	0.88	0.62	0.74	0.68	-0.22	-0.04	0.48	1.0	0.73	0.24	0.94	-0.29	0.91	-0.91	-0.91
Good Will	0.95	0.18	0.69	0.94		0.95	-0.73	0.93	0.61	0.88	0.9	0.13	0.8	0.7	0.52	0.69	-0.14	-0.1	0.55	0.93	0.81	0.21	0.87	-0.14	0.94	-0.91	-0.91
Total Liab	0.98	0.06	0.8	0.99	0.95		-0.67	0.95	0.57	0.94	0.97	-0.05	0.9	0.69	0.73	0.69	-0.13	-0.01	0.54	0.98	0.77	0.25	0.91	-0.21	0.9	-0.88	-0.91
Treasury Stock	-0.75	-0.54	-0.45	-0.64	-0.73	-0.67		-0.58	-0.69	-0.63	-0.62	-0.54	-0.75	-0.63	-0.27	-0.92	-0.12	-0.21	-0.89	-0.62	-0.93	0.01	-0.55	-0.48	-0.76	0.65	0.78
Intangible Assets	0.95	0.16	0.71	0.93	0.93	0.95	-0.58		0.55	0.84	0.88	0.04	0.77	0.74	0.6	0.59	-0.01	-0.12	0.46	0.93	0.72	0.36	0.8	-0.24	0.84	-0.77	-0.86
Common Stock	0.67	0.6	0.46	0.5	0.61	0.57	-0.69	0.55		0.58	0.46	0.37	0.64	0.89	0.29	0.57	0.19	0.13	0.67	0.45	0.79	0.18	0.35	0.33	0.56	-0.42	-0.51
Property Plant Equipment	0.92	0.06	0.86	0.93	0.88	0.94	-0.63	0.84	0.58		0.94	-0.11	0.93	0.62	0.75	0.59	-0.29	0.06	0.57	0.91	0.71	0.11	0.93	-0.19	0.82	-0.91	-0.78
Net Debt	0.92	-0.11	0.83	0.99	0.9	0.97	-0.62	0.88	0.46	0.94		-0.21	0.9	0.55	0.79	0.69	-0.29	0.03	0.47	0.99	0.71	0.21	0.96	-0.32	0.89	-0.92	-0.89
Retained Earnings	0.12	0.9	-0.25	-0.13	0.13	-0.05	-0.54	0.04	0.37	-0.11	-0.21		-0.04	0.31	-0.56	0.33	0.53	0.01	0.57	-0.13	0.43	-0.09	-0.25	0.82	0.09	0.08	-0.11
Net Receivables	0.9	0.15	0.86	0.88	0.8	0.9	-0.75	0.77	0.64	0.93	0.9	-0.04		0.65	0.78	0.75	-0.12	0.31	0.72	0.86	0.8	0.07	0.82	-0.02	0.78	-0.79	-0.8
Total Current Assets	0.77	0.5	0.53	0.62	0.7	0.69	-0.63	0.74	0.89	0.62	0.55	0.31	0.65		0.4	0.5	0.32	0.01	0.58	0.59	0.82	0.33	0.41	0.21	0.66	-0.46	-0.63
Short Term Debt	0.64	-0.35	0.83	0.74	0.52	0.73	-0.27	0.6	0.29	0.75	0.79	-0.56	0.78	0.4		0.39	-0.34	0.15	0.21	0.74	0.4	0.32	0.72	-0.42	0.51	-0.59	-0.53
Short Term Investments	0.73	0.32	0.45	0.68	0.69	0.69	-0.92	0.59	0.57	0.59	0.69	0.33	0.75	0.5	0.39		0.0	0.2	0.76	0.68	0.85	0.1	0.59	0.28	0.74	-0.62	-0.79
Current Deferred Revenue	-0.02	0.55	-0.23	-0.22	-0.14	-0.13	-0.12	-0.01	0.19	-0.29	-0.29	0.53	-0.12	0.32	-0.34	0.0		0.31	0.26	-0.23	0.16	-0.09	-0.48	0.57	-0.11	0.44	-0.06
Net Tangible Assets	0.01	0.14	0.3	-0.04	-0.1	-0.01	-0.21	-0.12	0.13	0.06	0.03	0.01	0.31	0.01	0.15	0.2	0.31		0.41	-0.05	0.2	-0.38	-0.07	0.2	-0.03	0.08	-0.07
Total Permanent Equity	0.65	0.66	0.43	0.48	0.55	0.54	-0.89	0.46	0.67	0.57	0.47	0.57	0.72	0.58	0.21	0.76	0.26	0.41		0.46	0.84	-0.24	0.4	0.56	0.55	-0.47	-0.59
Long Term Debt Total	0.94	-0.07	0.78	1.0	0.93	0.98	-0.62	0.93	0.45	0.91	0.99	-0.13	0.86	0.59	0.74	0.68	-0.23	-0.05	0.46		0.72	0.25	0.94	-0.3	0.91	-0.91	-0.91
Capital Surpluse	0.84	0.48	0.58	0.73	0.81	0.77	-0.93	0.72	0.79	0.71	0.71	0.43	0.8	0.82	0.4	0.85	0.16	0.2	0.84	0.72		0.11	0.6	0.33	0.84	-0.68	-0.82
Deferred Long Term Liab	0.24	-0.02	0.33	0.24	0.21	0.25	0.01	0.36	0.18	0.11	0.21	-0.09	0.07	0.33	0.32	0.1	-0.09	-0.38	-0.24	0.25	0.11		0.06	-0.19	0.08	-0.05	-0.07
Short Long Term Debt	0.84	-0.2	0.74	0.94	0.87	0.91	-0.55	0.8	0.35	0.93	0.96	-0.25	0.82	0.41	0.72	0.59	-0.48	-0.07	0.4	0.94	0.6	0.06		-0.39	0.86	-0.97	-0.81
Long Term Investments	-0.06	0.77	-0.25	-0.29	-0.14	-0.21	-0.48	-0.24	0.33	-0.19	-0.32	0.82	-0.02	0.21	-0.42	0.28	0.57	0.2	0.56	-0.3	0.33	-0.19	-0.39		-0.1	0.24	0.04
Net Invested Capital	0.89	0.06	0.6	0.91	0.94	0.9	-0.76	0.84	0.56	0.82	0.89	0.09	0.78	0.66	0.51	0.74	-0.11	-0.03	0.55	0.91	0.84	0.08	0.86	-0.1		-0.9	-0.95
Net Working Capital	-0.84	0.07	-0.7	-0.91	-0.91	-0.88	0.65	-0.77	-0.42	-0.91	-0.92	0.08	-0.79	-0.46	-0.59	-0.62	0.44	0.08	-0.47	-0.91	-0.68	-0.05	-0.97	0.24	-0.9		0.82
Capital Stock	-0.91	-0.1	-0.59	-0.91	-0.91	-0.91	0.78	-0.86	-0.51	-0.78	-0.89	-0.11	-0.8	-0.63	-0.53	-0.79	-0.06	-0.07	-0.59	-0.91	-0.82	-0.07	-0.81	0.04	-0.95	0.82

Click cells to compare fundamentals

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Competition

Predict ModivCare

In accordance with the recently published financial statements, ModivCare has a Beta of 0.486. This is 43.49% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

ModivCare Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ModivCare's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ModivCare could also be used in its relative valuation, which is a method of valuing ModivCare by comparing valuation metrics of similar companies.

ModivCare is currently under evaluation in beta category among its peers.

ModivCare Current Valuation Drivers

We derive many important indicators used in calculating different scores of ModivCare from analyzing ModivCare's financial statements. These drivers represent accounts that assess ModivCare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of ModivCare's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	1.9B	2.1B	1.3B	623.5M	561.2M	452.1M
Enterprise Value	2.2B	3.0B	2.3B	1.8B	1.6B	1.7B

ModivCare ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ModivCare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ModivCare's managers, analysts, and investors.

Environmental

Governance

Social

ModivCare Institutional Holders

Institutional Holdings refers to the ownership stake in ModivCare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ModivCare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ModivCare's value.

		Shares
Dimensional Fund Advisors, Inc.	2024-09-30	277.8 K
D. E. Shaw & Co Lp	2024-09-30	264.9 K
Madison Avenue Partners, Lp	2024-09-30	261.5 K
Geode Capital Management, Llc	2024-09-30	260.6 K
Renaissance Technologies Corp	2024-09-30	209.7 K
Marshall Wace Asset Management Ltd	2024-09-30	179.3 K
K2 Principal Fund Lp	2024-09-30	158.8 K
Charles Schwab Investment Management Inc	2024-09-30	147.4 K
Wolverine Asset Management Llc	2024-09-30	115.8 K
Coliseum Capital Management Llc	2024-09-30	3 M
Neuberger Berman Group Llc	2024-09-30	2 M

As returns on the market increase, ModivCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding ModivCare is expected to be smaller as well.

ModivCare Fundamentals

	Return On Equity	-2.58
	Return On Asset	0.0086
	Profit Margin	(0.07) %
	Operating Margin	0.01 %
	Current Valuation	1.29 B
	Shares Outstanding	14.28 M
	Shares Owned By Insiders	13.41 %
	Shares Owned By Institutions	88.78 %
	Number Of Shares Shorted	1.15 M
	Price To Earning	52.70 X
	Price To Book	19.01 X
	Price To Sales	0.02 X
	Revenue	2.75 B
	Gross Profit	432.54 M
	EBITDA	(23.33 M)
	Net Income	(204.46 M)
	Cash And Equivalents	72.7 M
	Cash Per Share	5.14 X
	Total Debt	1.14 B
	Debt To Equity	2.88 %
	Current Ratio	0.71 X
	Book Value Per Share	(1.19) X
	Cash Flow From Operations	(82.97 M)
	Short Ratio	2.11 X
	Earnings Per Share	(12.87) X
	Price To Earnings To Growth	3.33 X
	Target Price	12.38
	Number Of Employees	21.2 K
	Beta	0.49
	Market Capitalization	65.85 M
	Total Asset	1.77 B
	Retained Earnings	(24.44 M)
	Working Capital	(115.48 M)
	Net Asset	1.77 B

About ModivCare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ModivCare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ModivCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ModivCare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for ModivCare Stock Analysis

When running ModivCare's price analysis, check to measure ModivCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ModivCare is operating at the current time. Most of ModivCare's value examination focuses on studying past and present price action to predict the probability of ModivCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ModivCare's price. Additionally, you may evaluate how the addition of ModivCare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC